ILROG Team
@ilrogteam
ILROG Team Fantastic use of advanced planning and excellent results without auto, with all G3/4 tox during induction. This ain't your grandparent's mantle RT - highly effective with negligble toxicity! Maybe we should look at transplant-free survival as a new endpoint? 🧐🤔 #ASTRO23
ILROG Team Although BV-Nivo did the heavy lifting to CMR, reinforces the benefit of the rational integration of modern RT into evolving systemic therapy paradigms. With the support of groups like ILROG Team we can partner with our #HemeTeam colleagues #ASTRO23 ASH
A little late, but made it to the ASTRO ILROG Team joint session on challenging lymphoma cases! First up: challenging cases in abdominal/pelvic lymphomas with Dr. John Plastaras Penn Radiation Oncology Residency #ASTRO23
👉 ILROG Team mini atlas is a fantastic resource for involved site rather than involved field 👉NLPHL behaved more like NHL 👉IMRT planning considerations 👉48 second maliginancies/471 patients #ASTRO23
ILROG Team How to sim? 👉 Differences in breast position between arms up/down 👉 Benefits of breath hold 👉 Dose trapping when treating mediastinum/axilla - different priorities between men and women #ASTRO23
ILROG Team Shifting to a mediastinal case - "lymphoma is like a balloon without invading" 💡 post chemotherapy! So less concerned with chasing microscopic disease, especially as these masses "retract" superiorly #ASTRO23
Lots to learn at the ASTRO & ILROG Team joint session. Practical pearls from MD Anderson Cancer Center Bouthaina Dabaja MD on how to simulate/plan axillary &mediastinal cases for ISRT. Limit dose to the lungs, heart & breasts!Arms down to spare the breast in females. DIBH is your friend.
ILROG Team How to plan these cases? ✅ mostly anterior beams ✅ lung V5 matters (sorry Jeff Ryckman) ✅ dose constraints in the National Comprehensive Cancer Network (NCCN) #ASTRO23
Great presentation by Penn Radiation Oncology Residency John Plastaras on the management of challenging cases with RT. ILROG Team ASTRO #ASTRO23 Jillian Gunther Lena Specht
Fun, informative & interactive ILROG Team & ASTRO session led by David Hodgson. Bouthaina Dabaja MD Jillian Gunther Lena Specht John Plastaras #ASTRO23
Great comprehensive overview on RT for DLBCL prior/post CAR-T cell therapy by Brandon Imber #ASTRO2023 #ASTRO23 ➡️cytoreduction is key ‼️ So much to find out🤔 ILROG Team #radonc
Another ASTRO #ASTRO23 means another CART related RT oral by Omran Saifi, MD Great Job Mayo Clinic Florida Radiation Oncology Residency Mayo Clinic Radiation Oncology is proud!!
University of Toronto Michael Oertel Bradford Hoppe Beatrice Fregonese Memorial Sloan Kettering Radiation Oncology ILROG Team presenting on primary gastric DLBCL 👉 higher RT doses by disease status 👉 no diff PFS/OS by chemo cycles or pre-RT disease status #ASTRO23
Last but not least for the day: #HemeTeam ASTRO/ILROG Team myeloma educational session! 👀 come join heme rad oncs with ILROG Team in Beijing! #ASTRO23
Penny Fang When to consider surgery? ILROG Team steering committee survey for dose in bone + extramedullary #ASTRO23
Last hurrah for #ASTRO23 sessions as a Social Champion! QP 19: Modernizing TBI First up - Brandon Imber looking at boom boom versus "big boom" 👉 many tx with definitive intent 👉 80% CR - but can take time! ILROG Team
Should we extend breast cancer screening to Hodgkin Lymphoma patients treated with chemo only?? #radonc #lymphoma ILROG Team Rebecca Shakir David Cutter
